CN114685679A - Spyware mutant, preparation method thereof and application thereof in fluorescent protein system - Google Patents
Spyware mutant, preparation method thereof and application thereof in fluorescent protein system Download PDFInfo
- Publication number
- CN114685679A CN114685679A CN202011619571.5A CN202011619571A CN114685679A CN 114685679 A CN114685679 A CN 114685679A CN 202011619571 A CN202011619571 A CN 202011619571A CN 114685679 A CN114685679 A CN 114685679A
- Authority
- CN
- China
- Prior art keywords
- spyware
- mutant
- spycatcher
- fluorescent protein
- tev
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091006047 fluorescent proteins Proteins 0.000 title claims abstract description 28
- 102000034287 fluorescent proteins Human genes 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 108010076818 TEV protease Proteins 0.000 claims abstract description 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 9
- 238000000034 method Methods 0.000 claims description 10
- 108010082025 cyan fluorescent protein Proteins 0.000 claims description 9
- 108091005957 yellow fluorescent proteins Proteins 0.000 claims description 8
- 210000004899 c-terminal region Anatomy 0.000 claims description 3
- 239000000919 ceramic Substances 0.000 claims 2
- 239000002131 composite material Substances 0.000 claims 2
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 claims 2
- 229910010271 silicon carbide Inorganic materials 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 abstract description 45
- 102000004169 proteins and genes Human genes 0.000 abstract description 41
- 238000006243 chemical reaction Methods 0.000 abstract description 27
- 238000001976 enzyme digestion Methods 0.000 abstract description 9
- 238000005859 coupling reaction Methods 0.000 abstract description 8
- 238000010168 coupling process Methods 0.000 abstract description 7
- 230000008878 coupling Effects 0.000 abstract description 6
- 230000009257 reactivity Effects 0.000 abstract description 5
- 108091005804 Peptidases Proteins 0.000 abstract description 4
- 239000004365 Protease Substances 0.000 abstract description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract description 4
- 230000006337 proteolytic cleavage Effects 0.000 abstract description 3
- 239000000047 product Substances 0.000 description 17
- 150000001413 amino acids Chemical class 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 12
- 241000723792 Tobacco etch virus Species 0.000 description 9
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 6
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 6
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 6
- 230000005284 excitation Effects 0.000 description 6
- 239000005090 green fluorescent protein Substances 0.000 description 6
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- 230000001404 mediated effect Effects 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 108010078144 glutaminyl-glycine Proteins 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- CXRCVCURMBFFOL-FXQIFTODSA-N Ala-Ala-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O CXRCVCURMBFFOL-FXQIFTODSA-N 0.000 description 2
- LXAARTARZJJCMB-CIQUZCHMSA-N Ala-Ile-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LXAARTARZJJCMB-CIQUZCHMSA-N 0.000 description 2
- QYXNFROWLZPWPC-FXQIFTODSA-N Asn-Glu-Gln Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O QYXNFROWLZPWPC-FXQIFTODSA-N 0.000 description 2
- HAFCJCDJGIOYPW-WDSKDSINSA-N Asp-Gly-Gln Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O HAFCJCDJGIOYPW-WDSKDSINSA-N 0.000 description 2
- KNDCWFXCFKSEBM-AVGNSLFASA-N Asp-Tyr-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O KNDCWFXCFKSEBM-AVGNSLFASA-N 0.000 description 2
- HNAUFGBKJLTWQE-IFFSRLJSSA-N Gln-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)N)O HNAUFGBKJLTWQE-IFFSRLJSSA-N 0.000 description 2
- FXGRXIATVXUAHO-WEDXCCLWSA-N Gly-Lys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCCN FXGRXIATVXUAHO-WEDXCCLWSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- RQJUKVXWAKJDBW-SVSWQMSJSA-N Ile-Ser-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N RQJUKVXWAKJDBW-SVSWQMSJSA-N 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- KNKHAVVBVXKOGX-JXUBOQSCSA-N Lys-Ala-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KNKHAVVBVXKOGX-JXUBOQSCSA-N 0.000 description 2
- ISHNZELVUVPCHY-ZETCQYMHSA-N Lys-Gly-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O ISHNZELVUVPCHY-ZETCQYMHSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 2
- MSSXKZBDKZAHCX-UNQGMJICSA-N Phe-Thr-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O MSSXKZBDKZAHCX-UNQGMJICSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- UIMCLYYSUCIUJM-UWVGGRQHSA-N Pro-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 UIMCLYYSUCIUJM-UWVGGRQHSA-N 0.000 description 2
- NNFMANHDYSVNIO-DCAQKATOSA-N Ser-Lys-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NNFMANHDYSVNIO-DCAQKATOSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- SAKLWFSRZTZQAJ-GQGQLFGLSA-N Trp-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N SAKLWFSRZTZQAJ-GQGQLFGLSA-N 0.000 description 2
- OLYXUGBVBGSZDN-ACRUOGEOSA-N Tyr-Leu-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 OLYXUGBVBGSZDN-ACRUOGEOSA-N 0.000 description 2
- LVFZXRQQQDTBQH-IRIUXVKKSA-N Tyr-Thr-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O LVFZXRQQQDTBQH-IRIUXVKKSA-N 0.000 description 2
- SLLKXDSRVAOREO-KZVJFYERSA-N Val-Ala-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)N)O SLLKXDSRVAOREO-KZVJFYERSA-N 0.000 description 2
- UDNYEPLJTRDMEJ-RCOVLWMOSA-N Val-Asn-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)O)N UDNYEPLJTRDMEJ-RCOVLWMOSA-N 0.000 description 2
- XWYUBUYQMOUFRQ-IFFSRLJSSA-N Val-Glu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N)O XWYUBUYQMOUFRQ-IFFSRLJSSA-N 0.000 description 2
- KTEZUXISLQTDDQ-NHCYSSNCSA-N Val-Lys-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)O)N KTEZUXISLQTDDQ-NHCYSSNCSA-N 0.000 description 2
- 108010069020 alanyl-prolyl-glycine Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Chemical compound NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 2
- 108010015792 glycyllysine Proteins 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- -1 phenol compound Chemical class 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 108020001580 protein domains Proteins 0.000 description 2
- 108010020532 tyrosyl-proline Proteins 0.000 description 2
- ZVFVBBGVOILKPO-WHFBIAKZSA-N Ala-Gly-Ala Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O ZVFVBBGVOILKPO-WHFBIAKZSA-N 0.000 description 1
- AAWLEICNDUHIJM-MBLNEYKQSA-N Ala-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C)N)O AAWLEICNDUHIJM-MBLNEYKQSA-N 0.000 description 1
- ISCYZXFOCXWUJU-KZVJFYERSA-N Ala-Thr-Met Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(O)=O ISCYZXFOCXWUJU-KZVJFYERSA-N 0.000 description 1
- HKRXJBBCQBAGIM-FXQIFTODSA-N Arg-Asp-Ser Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N)CN=C(N)N HKRXJBBCQBAGIM-FXQIFTODSA-N 0.000 description 1
- XAJRHVUUVUPFQL-ACZMJKKPSA-N Asp-Glu-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O XAJRHVUUVUPFQL-ACZMJKKPSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 108010000916 Fimbriae Proteins Proteins 0.000 description 1
- DSPQRJXOIXHOHK-WDSKDSINSA-N Glu-Asp-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O DSPQRJXOIXHOHK-WDSKDSINSA-N 0.000 description 1
- JRCUFCXYZLPSDZ-ACZMJKKPSA-N Glu-Asp-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O JRCUFCXYZLPSDZ-ACZMJKKPSA-N 0.000 description 1
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 1
- GMTXWRIDLGTVFC-IUCAKERBSA-N Gly-Lys-Glu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMTXWRIDLGTVFC-IUCAKERBSA-N 0.000 description 1
- QMUHTRISZMFKAY-MXAVVETBSA-N His-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N QMUHTRISZMFKAY-MXAVVETBSA-N 0.000 description 1
- IDMNOFVUXYYZPF-DKIMLUQUSA-N Ile-Lys-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N IDMNOFVUXYYZPF-DKIMLUQUSA-N 0.000 description 1
- WNGVUZWBXZKQES-YUMQZZPRSA-N Leu-Ala-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O WNGVUZWBXZKQES-YUMQZZPRSA-N 0.000 description 1
- DCRWPTBMWMGADO-AVGNSLFASA-N Lys-Glu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DCRWPTBMWMGADO-AVGNSLFASA-N 0.000 description 1
- JPIDMRXXNMIVKY-VZFHVOOUSA-N Ser-Ala-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JPIDMRXXNMIVKY-VZFHVOOUSA-N 0.000 description 1
- SQBLRDDJTUJDMV-ACZMJKKPSA-N Ser-Glu-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O SQBLRDDJTUJDMV-ACZMJKKPSA-N 0.000 description 1
- HJEBZBMOTCQYDN-ACZMJKKPSA-N Ser-Glu-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HJEBZBMOTCQYDN-ACZMJKKPSA-N 0.000 description 1
- YMTLKLXDFCSCNX-BYPYZUCNSA-N Ser-Gly-Gly Chemical compound OC[C@H](N)C(=O)NCC(=O)NCC(O)=O YMTLKLXDFCSCNX-BYPYZUCNSA-N 0.000 description 1
- 239000012505 Superdex™ Substances 0.000 description 1
- MCDVZTRGHNXTGK-HJGDQZAQSA-N Thr-Met-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O MCDVZTRGHNXTGK-HJGDQZAQSA-N 0.000 description 1
- FDKDGFGTHGJKNV-FHWLQOOXSA-N Tyr-Phe-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N FDKDGFGTHGJKNV-FHWLQOOXSA-N 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000012407 engineering method Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000009851 immunogenic response Effects 0.000 description 1
- 230000017730 intein-mediated protein splicing Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 1
- 229960002064 kanamycin sulfate Drugs 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 108010038320 lysylphenylalanine Proteins 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 108010056582 methionylglutamic acid Proteins 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention discloses a spyware mutant, a preparation method thereof and application thereof in a fluorescent protein system. Belongs to the technical field of biological coupling. The spyware mutant SpyCatcher-N is obtained by connecting a flexible amino acid sequence with the original N end and C end of the spyware SpyCatcher, and a TEV protease recognizable sequence is inserted into the flexible amino acid sequence in the spyware mutant SpyCatcher-N to obtain the spyware mutant SpyCatcher-NTEV. The spyware mutant prepared by the invention has the advantages that on one hand, the spyware high reactivity is kept, and on the other hand, after the ligation reaction, the molecular weight of the Catcher protein can be reduced by protease enzyme digestion. Additional molecular weight was removed by means of proteolytic cleavage.
Description
Technical Field
The invention belongs to the technical field of biological coupling, and particularly relates to a spyware mutant, a preparation method thereof and application thereof in a fluorescent protein system.
Background
The bioconjugation technology is indispensable in the construction of protein-polymer complexes. Classical approaches to building complex protein-macromolecule topologies include "click" chemistry, native chemical ligation, traceless chemical ligation, and enzyme-mediated ligation of inteins, sortase a, sphenoid myxose 1, and the like. Highly reactive, non-natural reactive groups are often required in chemical attachment means, which may lead to protein yield or inactivate proteins. Enzyme-mediated ligation requires only a relatively short recognition sequence for the substrate to mediate the formation of the native peptide bond. However, enzyme-mediated ligation requires recognition sequences at specific positions on the substrate, and it is difficult to mediate the ligation to obtain branched products, which limits its application in constructing protein topologies and protein-based materials.
The genetically encoded polypeptide-protein reaction provides a powerful bioconjugation approach to e.g.SpyTag/SpyCatcher. The SpyTag/SpyCatcher is derived from a pilin domain that spontaneously forms isopeptide bonds, and they are entirely based on natural amino acids. The high irreversible reactivity and stable connection of the SpyTag/SpyCatcher enable the SpyTag/SpyCatcher to be widely applied to the fields of protein hydrogel, protein topological structure, synthetic drug carrier and synthetic biology of the Spy network. The SpyTag/SpyCatcher reaction pair is continuously developing, and has a super-charge and disorder SpyCatcher (-), and the SpyTag-SpyCatcher reaction pair is orthogonal to the SpyTag-SnoopCatcher reaction pair and the SpyTag002-SpyCatcher002 reaction pair with faster reaction rate. The resolution of proteins similar to the CnaB2 domain can result in similar Tag-Catcher reaction pairs, such as SdyTag-Sdycatcher reaction pairs. However, for most Catcher proteins, the reactive group is often near the N-terminus of the protein, and is less frequently located at the C-terminus or in a protein segment. Furthermore, the Catcher protein often leaves a molecular weight of about 10kDa on the complex after the ligation reaction, which may affect the properties of the final product or elicit an immunogenic response in therapy. Recently, a polypeptide-polypeptide coupling mode mediated by spyware ligase spyLigase is developed by the Howarth task group, and spyware is further split into spyware ligase and a K label. This method significantly reduces the molecular weight of the linking moiety, but the reactivity is greatly affected. Therefore, we have developed an alternative method to search for spyware mutants, which on the one hand maintain the high reactivity of spyware and on the other hand after the ligation reaction the Catcher protein can be reduced in molecular weight by protease cleavage. Additional molecular weight was removed by means of proteolytic cleavage.
Disclosure of Invention
The present application addresses the deficiencies of the prior art and aims to provide a spyware mutant, a preparation method thereof and an application thereof in a fluorescent protein system. The spyware mutant prepared by the invention has the advantages that on one hand, the spyware high reactivity is kept, and on the other hand, after the ligation reaction, the molecular weight of the Catcher protein can be reduced by protease enzyme digestion. Additional molecular weight was removed by means of proteolytic cleavage.
The technical scheme of the invention is as follows:
the selected model proteins, yellow fluorescent protein and cyan fluorescent protein, are both derived from green fluorescent protein. Threonine (T203) at the 203 th position of the green fluorescent protein is mutated into tyrosine to obtain yellow fluorescent protein, and pi-pi interaction between a tyrosine lateral group and chromophore enables the excitation wavelength and the emission wavelength of the fluorescent protein to be subjected to red shift, wherein the excitation wavelength is 517nm, and the emission wavelength is 530 nm. The tyrosine 66 (Y66) of the green fluorescent protein is mutated into tryptophan to obtain the cyan fluorescent protein, the side group of the tryptophan enables the chromophore to finally form an indole ring instead of a phenol compound, the excitation wavelength is 435nm, and the emission wavelength is 477 nm.
In addition to the original protein domain re-splitting can get smaller connecting parts, the protein structure cycle arrangement (circular mutation) and protein engineering editing can get the same effect. If cyclic arrangement and protein engineering editing are carried out on the spyware, the original N end and C end in the spyware structure are connected by flexible segments, and the second annular structure in the spyware structure is split to obtain a new protein structure domain N end and a new protein structure domain C end. In terms of the secondary structure of the protein, the sequence before the second loop structure of spyware is edited to the C-terminal of the protein, namely, the lysine of the reaction site is moved to the C-terminal. In a new secondary structure, a Tobacco Etch Virus (TEV) enzyme recognition sequence ENLYFQG is inserted into a glycine and serine flexible region connected with the C end and the first two beta-strips of the spyware, so that enzyme digestion can be carried out after a spyware label reacts with a spyware mutant, and redundant parts of the spyware are removed, thereby achieving the purpose of reducing the molecular weight of the spyware.
A spy catcher mutant, which is spy catcher-NTEVThe amino acid sequence is shown as SEQ ID NO. 1.
The spyware mutant SpyCatcher-N is obtained by connecting a flexible amino acid sequence with the original N end and C end of the spyware SpyCatcher, and a TEV protease recognizable sequence is inserted into the flexible amino acid sequence in the spyware mutant SpyCatcher-N to obtain the spyware mutant SpyCatcher-NTEVWherein the spyware mutants Spycatcher-N and Spycatcher-NTEVThe new N end and C end are generated in the second ring part of the spyware, namely the second ring area for splitting the spyware, and the new N end and C end of the mutant can be generated.
The TEV protease recognizable sequence is ENLYFQG.
The flexible amino acid sequence is (GGS)3。
The spyware mutant Spycatcher-N has an amino acid sequence shown in SEQ ID NO. 2.
A preparation method of a spy catcher mutant comprises the following steps: the spyware mutant SpyCatcher-N is obtained by connecting a flexible amino acid sequence with the original N end and C end of the spyware SpyCatcher, and the TeV protease recognizable sequence is inserted into the flexible amino acid sequence in the spyware mutant SpyCatcher-N to obtain the spyware mutant SpyCatcher-NTEV。
An application of spyware mutant in a fluorescent protein system.
The spyware mutant is applied to a fluorescent protein model system, and the fluorescent protein is cyan fluorescent protein or yellow fluorescent protein.
The beneficial technical effects of the invention are as follows:
the invention mainly redesigns spyware, reduces the molecular weight after spyware reaction and develops a micro-trace polypeptide-polypeptide coupling method. Protein engineering editing is carried out on the spyware by utilizing a circular arrangement method to obtain a spyware mutant SpyCatcher-N, SpyCatcher-NTEV. Then spy tag-spy catcher mutantSpyCatcher-NTEVThe system is applied to a fluorescent protein plastid system, performs coupling reaction and enzyme digestion reaction, verifies the correctness of corresponding products, and effectively reduces spyware mutant SpyCatcher-NTEVThe molecular weight of (a) and the feasibility of a spyware redundant part method is reduced by a seal cycle arrangement method.
Drawings
Fig. 1 is a topology diagram of a cyclic arrangement of spyware in an embodiment of the present invention.
FIG. 2 shows spyware and spyware mutant SpyCatcher-N, SpyCatcherN in an embodiment of the present inventionTEVAnd the model protein SpyCatcher-NTEV-The gene sequence of CFP.
FIG. 3 shows spy label-yellow fluorescent protein and spy catcher mutant-NTEVCyan fluorescent protein reaction scheme.
FIG. 4 shows exemplary embodiments of the present invention, namely spyware-N, spyware-NTEVAnd (4) amino acid sequence comparison.
FIG. 5 shows the SDS-PAGE analysis of the coupled product and the cleaved product in the examples of the present invention; (b) MALDI-TOF analysis of the molecular weight of the coupled product and the cleaved product.
Detailed Description
The present invention will be described in detail with reference to the following examples and drawings.
Example 1
The gene design is as follows:
the selected model proteins, yellow fluorescent protein and cyan fluorescent protein, are both derived from green fluorescent protein. Threonine 203 (T203) at the 203 th site of the green fluorescent protein is mutated into tyrosine to obtain yellow fluorescent protein, and the side group of the tyrosine interacts with the pi-pi of chromophore to red shift the excitation wavelength and the emission wavelength of the fluorescent protein, wherein the excitation wavelength is 517nm, and the emission wavelength is 530 nm. The tyrosine 66 (Y66) of the green fluorescent protein is mutated into tryptophan to obtain the cyan fluorescent protein, the side group of the tryptophan enables the chromophore to finally form an indole ring instead of a phenol compound, the excitation wavelength is 435nm, and the emission wavelength is 477 nm.
In addition to the original protein domain re-splitting can get smaller connecting parts, the protein structure cycle arrangement (circular mutation) and protein engineering editing can get the same effect. If cyclic arrangement and protein engineering editing are carried out on the spyware, the original N end and C end in the spyware structure are connected by flexible segments, and the second annular structure in the spyware structure is split to obtain a new protein structure domain N end and a new protein structure domain C end. From the secondary structure of the protein, the sequence before the second loop structure of spyware is edited to the C-terminus of the protein, i.e., the lysine at the reaction site is moved to the C-terminus. In the novel secondary structure, a Tobacco Etch Virus (TEV) enzyme recognition sequence ENLYFQG is inserted into a glycine and serine flexible region connected with the C end and the first two beta-bars of the spyware, so that the spyware can be subjected to enzyme digestion after the reaction of a spyware label and a spyware mutant, and the redundant part of the spyware is removed to achieve the purpose of reducing the molecular weight of the spyware. As shown in fig. 1.
After a circularly arranged protein engineering method, the spyware mutant Spycatcher-N, SpyCatcher-NTEVAnd spyware amino acid sequence pairs are shown in FIG. 4. The flexible amino acid (GGS)3 sequence is connected with the original N end and C end of the spyware to obtain a spyware mutant SpyCatcher-N, and the TEV enzyme recognition sequence ENLYFQG is inserted into the flexible chain (GGS)3 sequence of the spyware mutant SpyCatcher-N to obtain a spyware mutant SpyCatcher-NTEV. Spyware mutants SpyCatcher-N and SpyCatcher-NTEVThe new N end and C end are generated in the second ring part of the spyware, namely the second ring region of the spyware is split, so that the new N end and C end of two mutants can be generated. DAHID in the spyware amino acid sequence is not shown in the crystal structure and can be considered as a disordered sequence, and is therefore discarded during the cyclic alignment.
Example 2
The plasmid was constructed as follows:
for exploring spy tags and spy captors-NTEVWhen the fluorescent protein is applied to a model system, yellow fluorescent protein and cyan fluorescent protein are selected as model proteins, and spy tag-yellow fluorescent protein (SpyTag-YFP) and spy captor-N are constructedTEV-Cyan fluorescent protein (BDtag-CFP). To construct spy marksTaking a plasmid containing a yellow fluorescent protein sequence as a template and a DNA single-stranded fragment containing an enzyme cutting site sequence as a primer, and amplifying a spy tag-yellow fluorescent protein target sequence containing an enzyme cutting site by PCR (polymerase chain reaction). And then the spy tag-yellow fluorescent protein fragment is inserted into a pET-28b vector containing the same enzyme cutting site by a double enzyme cutting method. Spy catcher-NTEVThe cyan fluorescent protein (BDTag-CFP) was constructed in the same manner.
TABLE 1 Experimental plasmids
TABLE 2 Experimental strains
Name of Strain | Source | Use of |
Escherichia coli DH-5 alpha | Kangshi Century (CWBIO) | Cloning of genes |
Escherichia coli BL21(DE3) | Kangshi Century (CWBIO) | Protein expression |
TABLE 3 primer Gene sequences
Example 3
Protein purification and expression
Contains spy tag-yellow fluorescent protein (SpyTag-YFP) and spy catcher-NTEVAfter the plasmid pET-28b of-cyan fluorescent protein (BDtag-CFP) was confirmed by sequencing, it was transferred into BL21(DE3) competent cells and plated, and cultured overnight at 37 ℃ in an incubator. Single colonies were picked on the plates and cultured overnight at 37 ℃ in a shaking incubator in LB medium containing 0.33mg/mL kanamycin. Overnight culture medium was taken as 1: adding 100 proportion of fresh 1L LB culture medium containing 0.33mg/mL kanamycin sulfate, shaking culturing at 37 deg.C to OD6000.4-0.6, changing the temperature of the shaking incubator to 16 ℃ for overnight culture, and simultaneously adding IPTG to the final concentration of 1mM to induce the escherichia coli to express the target protein. After the expression is finished, the bacteria are collected by centrifugation, the supernatant is discarded, and the target protein is purified and eluted by using non-denaturing conditions. The target protein was collected and purified by a gel size exclusion chromatography column (Superdex 200 inch 10/300GL, GE Healthcare) of a protein rapid purification liquid chromatography system, and the mobile phase was 1 XP buffered saline (2mM potassium dihydrogen phosphate, 10mM disodium hydrogen phosphate, 137mM sodium chloride, 2.7mM potassium chloride, pH 7.4).
Example 4
Spy catcher mutant Spycatcher-NTEVApplication to fluorescent protein model systems
Measuring spy tag-yellow fluorescent protein (SpyTag-YFP) and spy catcher mutant-N with ultramicro spectrophotometer (P330, Implen)TEV-concentration of cyan fluorescent protein. Reaction according to spy label-yellow fluorescent protein: spy catcher mutant-NTEVThe molar ratio of-cyan fluorescent protein ═ 1:1.2 (n: n) was reacted at 4 ℃ for 24 hours. The reaction schemes for the extracellular reaction and TEV cleavage reaction are shown in FIG. 3.
When the reaction product is subjected to TEV enzyme digestion reaction, coupling products are adopted: TEV enzyme 1:3 (n: n, molar ratio) was digested at 37 ℃ for 24 hours. The reaction was quenched by addition of 5 Xloading buffer immediately after the reaction time was reached. SDS-PAGE electrophoresis is used for representing reaction mixed liquor and reaction progress, and a multifunctional fluorescence analyzer is used for quantifying the proportion of reactants and products in protein reaction liquor.
The SDS-PAGE result of FIG. 5(a) shows that the band of the coupled product is substantially disappeared after the coupled product is added with TEV enzyme, and a new protein band appears below the band of the coupled product, which is presumed to be an enzyme-cleaved product. Thus, it is considered that the substrate is cleaved to almost completion by cleavage reaction at 37 ℃ for 24 hours. And (3) performing mass spectrum characterization on samples corresponding to the bands of the coupling product and the enzyme digestion product, wherein MALDI-TOF experimental results and theoretical value errors in the figure 5(b) are within an allowable range, and further proving the molecular weights of the coupling product and the enzyme digestion product, thereby indicating that the coupling reaction and the enzyme digestion reaction obtain expected products.
The SpyCatcher-N amino acid sequence is GKTISTWISDGQVKDFYLYPGKYTEVETAAPGDYEVATAITFTVNEQGQVTVNGKATKGGSGGSGGSEDSATHIKFSKRDEDGKELAGATMELRDS;
SpyCatcher-N in the inventionTEVThe amino acid sequence is GKTISTWISDGQVKDFYLYPGKYTEVETAAPGDYEVATAITFTVNEQGQVTVNGKATKGGSENLYFQGGGSEDSATHIKFSKRDEDGKELAGATMELRDS.
SEQUENCE LISTING
<110> Jiangsu Beiottak Biotechnology Ltd
<120> spy catcher mutant, preparation method thereof and application thereof in fluorescent protein system
<130> 2
<160> 2
<170> PatentIn version 3.3
<210> 1
<211> 96
<212> PRT
<213> Artificial sequence
<400> 1
Gly Lys Thr Ile Ser Thr Trp Ile Ser Asp Gly Gln Val Lys Asp Phe
1 5 10 15
Tyr Leu Tyr Pro Gly Lys Tyr Thr Glu Val Glu Thr Ala Ala Pro Gly
20 25 30
Asp Tyr Glu Val Ala Thr Ala Ile Thr Phe Thr Val Asn Glu Gln Gly
35 40 45
Gln Val Thr Val Asn Gly Lys Ala Thr Lys Gly Gly Ser Gly Gly Ser
50 55 60
Gly Gly Ser Glu Asp Ser Ala Thr His Ile Lys Phe Ser Lys Arg Asp
65 70 75 80
Glu Asp Gly Lys Glu Leu Ala Gly Ala Thr Met Glu Leu Arg Asp Ser
85 90 95
<210> 2
<211> 100
<212> PRT
<213> Artificial sequence
<400> 2
Gly Lys Thr Ile Ser Thr Trp Ile Ser Asp Gly Gln Val Lys Asp Phe
1 5 10 15
Tyr Leu Tyr Pro Gly Lys Tyr Thr Glu Val Glu Thr Ala Ala Pro Gly
20 25 30
Asp Tyr Glu Val Ala Thr Ala Ile Thr Phe Thr Val Asn Glu Gln Gly
35 40 45
Gln Val Thr Val Asn Gly Lys Ala Thr Lys Gly Gly Ser Glu Asn Leu
50 55 60
Tyr Phe Gln Gly Gly Gly Ser Glu Asp Ser Ala Thr His Ile Lys Phe
65 70 75 80
Ser Lys Arg Asp Glu Asp Gly Lys Glu Leu Ala Gly Ala Thr Met Glu
85 90 95
Leu Arg Asp Ser
100
Claims (8)
1. The spyware mutant is characterized by being SpyCatcher-NTEVThe amino acid sequence is shown as SEQ ID NO. 1.
2. The spyware mutant according to claim 1, wherein the spyware mutant SpyCatcher-N is obtained by linking a flexible amino acid sequence to the original N-terminal and C-terminal of spyware SpyCatcher, and a TEV protease recognizable sequence is inserted into the flexible amino acid sequence of spyware mutant SpyCatcher-N to obtain spyware mutant SpyCatcher-NTEVWherein the spyware mutants SpyCatcher-N and SpyCatcher-NTEVAnd the new N end and C end are generated in the second ring part of the spyware, namely the second ring region for splitting the spyware, so that the new N end and C end of the mutant can be generated.
3. The spyware mutant according to claim 1, wherein the TEV protease recognizable sequence is ENLYFQG.
4. The method for preparing low-temperature normal-pressure sintered silicon carbide composite ceramic according to claim 1, wherein the flexible amino acid sequence is (GGS)3。
5. The method for preparing the low-temperature normal-pressure sintered silicon carbide composite ceramic according to claim 1, wherein the spyware mutant SpyCatcher-N has an amino acid sequence shown in SEQ ID No. 2.
6. A method for preparing spyware mutants according to any one of claims 1 to 5, wherein the method comprises: the spyware mutant SpyCatcher-N is obtained by connecting a flexible amino acid sequence with the original N end and C end of the spyware SpyCatcher, and the TEV protease recognizable sequence is insertedObtaining spyware mutant SpyCatcher-N from the flexible amino acid sequence in spyware mutant SpyCatcher-NTEV。
7. Use of a spy-catch mutant according to any one of claims 1-5 in a fluorescent protein system.
8. Use of spyware mutant according to claim 7 in a fluorescent protein model system, wherein the fluorescent protein is cyan fluorescent protein or yellow fluorescent protein.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011619571.5A CN114685679A (en) | 2020-12-30 | 2020-12-30 | Spyware mutant, preparation method thereof and application thereof in fluorescent protein system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011619571.5A CN114685679A (en) | 2020-12-30 | 2020-12-30 | Spyware mutant, preparation method thereof and application thereof in fluorescent protein system |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114685679A true CN114685679A (en) | 2022-07-01 |
Family
ID=82135239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011619571.5A Pending CN114685679A (en) | 2020-12-30 | 2020-12-30 | Spyware mutant, preparation method thereof and application thereof in fluorescent protein system |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114685679A (en) |
-
2020
- 2020-12-30 CN CN202011619571.5A patent/CN114685679A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210371467A1 (en) | Split inteins with exceptional splicing activity | |
CN105061581B (en) | Can gene code holoprotein catenne preparation method | |
CN110452303B (en) | Method for covalently linking nucleic acid and peptide or protein and application thereof | |
CN113195521A (en) | Mtu Delta I-CM intein variants and uses thereof | |
CN114381471B (en) | Application of auxiliary protein in recombinant protein production and fusion expression system | |
JPWO2014097733A1 (en) | Method for producing human epidermal growth factor | |
CN114685679A (en) | Spyware mutant, preparation method thereof and application thereof in fluorescent protein system | |
CN113045633A (en) | Design of protein heterogeneous entanglement primitive and preparation method of complex catenane structure | |
CN111073925B (en) | High-efficiency polypeptide-polypeptide coupling system and method based on disordered protein coupling enzyme | |
CN113774039B (en) | Recombinant DNA polymerase and application thereof | |
CN110540601B (en) | Recombinant PLB-hEGF fusion protein and application thereof | |
CN111808177B (en) | Signal peptide for improving protein expression quantity and application thereof | |
US20160319287A1 (en) | Atypical inteins | |
CN110636859B (en) | Methods for producing refolded recombinant humanized ranibizumab | |
CN118271390A (en) | Preparation method and application of spy catcher mutant | |
RU2441072C1 (en) | FUSION PROTEIN, ESCHERICHIA COLI STRAIN BEING FUSION PROTEIN PRODUCER AND METHOD FOR PRODUCING METHIONINE-FREE HUMAN INTERFERON ALPHA-2b OF SUCH FUSION PROTEIN | |
US20160009779A1 (en) | Novel fusion tags and expression vector system for the expression of human parathyroid hormone (rhpth) | |
CN110724202A (en) | ADAMTS13 substrate with histidine tag as well as preparation method and application thereof | |
CN110904068A (en) | CK-MB type creatine kinase isozyme, preparation method and application | |
WO2024119434A1 (en) | Solubilization-assisting short peptide tag with acidic surface for improving expression efficiency of recombinant protein | |
CN116496365B (en) | Acidic surface-assisted dissolution short peptide tag for improving recombinant protein expression efficiency | |
CN114807101B (en) | Fusion protein containing bovine enterokinase light chain protein, expression vector and recombinant engineering bacteria thereof | |
CN112851765B (en) | Method for covalently linking protein or peptide to nucleic acid | |
CN111197041B (en) | Method for preparing medaka enterokinase active subunit, product and application thereof | |
KR102009709B1 (en) | Method of preparing human parathyroid hormone 1-84 using fusion polypeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |